Keyphrases
Randomized Controlled Trial
100%
Hormone Replacement Therapy
100%
Estrogen Replacement Therapy
100%
Bone Mineral Density
100%
Frail Elderly
100%
Density Response
100%
Confidence Interval
57%
Placebo
57%
Between-group Difference
57%
Lumbar Spine
28%
Clinically Significant
14%
Randomized Placebo-controlled Trial
14%
Moderate to Severe
14%
Alkaline Phosphatase Level
14%
Dual-energy X-ray Absorptiometry
14%
Primary Outcome Measure
14%
Result-oriented
14%
Medroxyprogesterone Acetate
14%
Bone Turnover Markers
14%
Osteoporotic Fractures
14%
Physical Frailty
14%
Total Hip
14%
Intention-to-treat Analysis
14%
Bone Alkaline Phosphatase
14%
University-based Research
14%
Conjugated Estrogens
14%
N-telopeptide
14%
Elderly Women
14%
US University
14%
Osteogenic Activity
14%
Osteoprotective Effect
14%
Tri-monthly
14%
Osteoporosis Prevention
14%
Nursing and Health Professions
Hormone Substitution
100%
Estrogen Therapy
100%
Bone Density
100%
Frail Elderly
100%
Placebo
71%
Confidence Interval
57%
Frailty
14%
Dual Energy X Ray Absorptiometry
14%
Fragility Fracture
14%
Medroxyprogesterone Acetate
14%
Intention to Treat Analysis
14%
Telopeptide
14%
Bone Turnover
14%
Alkaline Phosphatase
14%